共 50 条
- [1] Mutational Landscape and Genetic Determinants of Response to Trimodality Therapy in Muscle-Invasive Bladder Cancer [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 108 (03): : E861 - E861
- [3] Trimodality Bladder Preservation Therapy for Muscle-Invasive Bladder Cancer [J]. JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2013, 11 (08): : 952 - 960
- [4] Bladder Preserving Trimodality Therapy for Muscle-Invasive Bladder Cancer [J]. Current Oncology Reports, 2018, 20
- [5] Subtyping Muscle-Invasive Bladder Cancer to Assess Clinical Response to Trimodality Therapy [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2017, 99 (02): : S118 - S118
- [7] Outcomes of trimodality bladder-sparing therapy for muscle-invasive bladder cancer [J]. CUAJ-CANADIAN UROLOGICAL ASSOCIATION JOURNAL, 2020, 14 (04): : 122 - 129
- [10] Nomograms Predicting Response to Therapy and Outcomes After Bladder-Preserving Trimodality Therapy for Muscle-Invasive Bladder Cancer [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2013, 86 (02): : 311 - 316